Key takeaways GLP-1 medications do not inherently cause muscle wasting. Most weight lost on semaglutide or tirzepatide is fat , not muscle. Some lean-mass loss during weight loss reflects adaptive remodeling , not pathology. Adequate protein intake and resistance training significantly reduce muscle loss during GLP-1 therapy. Do GLP-1 Medications Cause Muscle Wasting
A 2024 FDA investigation of seized GLP-1 peptide samples found that 15% contained bacterial endotoxins exceeding safety limits
Careful use under medical supervision is essential to minimize risks.
A 2022 study in Nutrients showed slight weight loss in participants using red orange extract, but experts caution against placing too much confidence in these results
Nausea, constipation, reflux, and appetite changes are still possible
Beyond their established role in T2D, GLP-1RAs are under investigation for potential therapeutic applications in additional clinical domains: non-alcoholic fatty liver disease (NAFLD) [22], neurodegenerative conditions [23], and addiction reduction(including smoking, alcohol use disorder, and cocaine use disorder, putatively via mechanisms analogous to those underlying appetite suppression) [23]